Biotech start-up raising DKK 130 million to produce natural vitamins through fermentation instead of chemistry

image Photo: Biosyntia

Biosyntia develops sustainable vitamins based on innovative biotechnology as an alternative to traditional, chemical production. The investment from EIFO, among others, will help to start the production and ensure that Biosyntia’s first commercial product lands in the consumers’ shopping cart.

It is not without risk when it is cutting edge technology you have at hand. It requires trust and faith from the investors. EIFO has shown us that trust, and we are very proud of that
— Martin Plambech, CEO, Biosyntia

The ambition is to become the world leader within the industry, and in Biosyntia they believe that they can bring life to many processes that will enable the production of ingredients more naturally and sustainably than today